Literature DB >> 1063911

Causes of death in adults with acute leukemia.

H Y Chang, V Rodriguez, G Narboni, G P Bodey, M A Luna, E J Freireich.   

Abstract

The causes of death were investigated in 315 adults with acute leukemia during a 7-year period (1966-1972). Infection alone or in combination was the most common cause (75%), followed by hemorrhage (24%) and organ failure (9%). Most of the infections were either systemic or pulmonary. Seventy-five percent of the systemic infections and 72% of the pneumonias were caused by bacteria. Klebsiella pneumoniae, Escherichia coli and Pseudomonas aeruginosa were the most frequent organisms isolated. After 1968, there was a sharp decrease in the number of fatal infections caused by Pseudomonas aeruginosa and a marked increase in the incidence of fatal infections caused by Klebsiella spp. and E. coli. Infections caused by Gram-positive cocci occurred in only 3% of the cases. The incidence of systemic fungal infections was 13%; most common fungi causing infection were Candida spp. and Aspergillus spp. Eighty-five percent of 159 patients with a terminal neutrophil count of less than 100/mm3 died of infection, compared to 48% of 62 patients with a terminal neutrophil count of greater than 1000/mm3. Hemorrhage was mostly due to thrombocytopenia (61%) and disseminated intravascular coagulation (12%). This study indicates that infection continues to be the most common cause of death in patients with acute leukemia. Although advances in antibiotic therapy have changed the distribution of causative organisms, ultimate control of infection requires further improvements in supportive care measures which rectify impairments in the patients' host defense mechanisms.

Entities:  

Mesh:

Year:  1976        PMID: 1063911     DOI: 10.1097/00005792-197605000-00005

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  48 in total

1.  Inducing Apoptosis through Upregulation of p53: Structure-Activity Exploration of Anthraquinone Analogs.

Authors:  Abiodun Anifowose; Ayodeji A Agbowuro; Ravi Tripathi; Wen Lu; Chalet Tan; Xiaoxiao Yang; Binghe Wang
Journal:  Med Chem Res       Date:  2020-06-07       Impact factor: 1.965

Review 2.  Shock and Early Death in Hematologic Patients with Febrile Neutropenia.

Authors:  Mariana Guarana; Marcio Nucci; Simone A Nouér
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

Review 3.  Bacterial Pneumonia in Patients with Cancer: Novel Risk Factors and Management.

Authors:  Justin L Wong; Scott E Evans
Journal:  Clin Chest Med       Date:  2017-03-01       Impact factor: 2.878

Review 4.  Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts.

Authors:  G Maschmeyer
Journal:  Drugs       Date:  1993       Impact factor: 9.546

5.  Assessment of host defence against infection during chemotherapy of Hodgkin's disease.

Authors:  I Addison; J Babbage; M Gandossini; R Souhami
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

6.  [Development of the risk of infection in the child with leukemia].

Authors:  P Lutz; G Delage; G E Rivard; G Berdnikoff
Journal:  Can Med Assoc J       Date:  1983-09-01       Impact factor: 8.262

7.  Double beta-lactam regimen compared to an aminoglycoside/beta-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.

Authors:  J H Joshi; K A Newman; B W Brown; R S Finley; R L Ruxer; M A Moody; S C Schimpff
Journal:  Support Care Cancer       Date:  1993-07       Impact factor: 3.603

8.  Septicemia in children with leukemia.

Authors:  Y DeClerck; D DeClerck; G E Rivard; P Benoit
Journal:  Can Med Assoc J       Date:  1978-06-24       Impact factor: 8.262

9.  Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases.

Authors:  W Kern; E Kurrle; T Schmeiser
Journal:  Infection       Date:  1990 May-Jun       Impact factor: 3.553

10.  Increased aminoglycoside dosage requirements in hematologic malignancy.

Authors:  R G Zeitany; N S El Saghir; C R Santhosh-Kumar; M A Sigmon
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.